Usage: Sacubitril (development code ahu-377) is an antihypertensive drug used in combination with
valsartan, and it is also a drug for the treatment of heart failure.
Properties
Summary
Sacubitril (INN developmental code name AHU-377) is an antihypertensive drug used in combination with valsartan. The combination drug valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. It was approved under the FDA's priority review process for use in heart failure on July 7, 2015.
CRO
